Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure?

QJM: An International Journal of Medicine

Volumn 92, Issue 5, 1999, Pages 275-282

  Feest, T G ^a   Dunn, E J ^a   Burton, C J ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; DIABETES CONTROL; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; HEALTH CARE QUALITY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL;

EID: 0032897913     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/92.5.275     Document Type: Article

References (33)

1. United States Renal Data System. USROS 1997 Annual Data Report. Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997.
2. Lippert J, Ritz E, Schwarzbeck A, Schneider P. The rising tide of end stage renal failure from diabetic nephropathy type II-an epidemiological analysis. Nephrol Dial Transplant 1995; 10:462-647.
3. Marcelli D, Spotti D, Conte F, Limido A, Malberti F, Locatelli F. Prognosis of diabetic patients on dialysis: analysis of Lombardy Registry data. Nephrol Dial Transplant 1995; 10:1895-901.
4. Roderick PJ, Ferris C, Feest TG. The provision of renal replacement therapy for adults in England and Wales : recent trends and future directions. QJM 1998; 91:581-7.
5. Viberti GC, Mogensen CE, Passa P, Bilous R, Mangili R, Raine A. The St Vincent Declaration 1994. The kidney and hypertension in diabetes mellitus. Mogensen CE, ed. Kluwer Academic Publishers, 1994:515-27.
6. Borch-Johnsen K, Kreiner S. Proteinuria-value as a predictor of cardiovascular mortality in insulin dependant diabetes mellitus. Br Med J 1987; 294:1651-4.
7. Borsch-Johnsen K, Anderson PK, Deckert T. The effect of proteinuria on relative mortality in type I (insulin dependant) diabetes mellitus. Diabetologia 1985; 28:590-6.
8. Raine AEG, Margreiter R, Brunner FP, et al. Report on the management of renal failure in Europe XXII 1991. Nephrol Dial Transplant 1992; 7 (suppl. 2):7-35.
9. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependant diabetes mellitus. N Engl Med J 1993; 329:977-86.
10. The DCCT Research Group. The effect of intensive treatment on the development and progression of diabetic nephropathy in the DCCT. Kidney Int J 1995; 47:1703-21.
11. Chowdury TA, Kumar S, Barnett AH, Bari SC. Nephropathy in type I diabetes: the role of genetic factors. Diabetic Med 1995; 12:1059-67.
12. Tarnow L. Genetic pattern of diabetic nephropathy. Nephrol Dial Transplant 1996; 11:410-12.
13. Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori Y. Predictors of the progression of diabetic nephropathy and the beneficial effect of ACE inhibitors in NIDDM patients. Diabetologia 1997; 40:405-11.
14. Breyer JA, Bain RP, Evans JK, Nahman NS, Lewis EJ, Cooper M, McGill J, Beru T. Predictors of the progression of renal insufficiency in patients with IDDM and overt diabetic nephropathy. Kidney Int 1996; 50:1651-8.
15. Mogensen CE. Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med I 1994; 285:685-8.
16. Parving HH, Anderson AR, Smidt UM, Svendsen PA. Early aggressive antihypertensive therapy reduces the rate of decline of kidney function in diabetic nephropathy. Lancet 1983; i:1175-8.
17. Parving HH, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P. Benefits of longterm antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int 1996; 49:1778-82.
18. Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans; importance of therapeutic selection. Kidney Int 1992; 41:912-19.
19. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of ACE inhibitors on diabetic nephropathy. N Engl J Med 1993; 329:1456-62.
20. Bakris GL, Copley B, Vicknair N, Sadler R, Leurgas S. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 1996; 50:1641-50.
21. Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobsen H. Effect of restricting dietary protein on the progression of renal failure in patients with IDDM. N Engl J Med 1991; 324:78-84.
22. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 1996; 124:627-32.
23. Raal FJ, Kalk WJ, Lawson M, Esser JD, Buys R, Fourie L, Panz VR. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a six month prospective study. Am I Clin Nutr 1994; 60:579-85.
24. Mulec H, Johnsen SA, Wiklund O, Björk S. Cholesterol: A renal risk factor in diabetic nephropathy? Am J Kidney Dis 1993; 22:196-201.
25. Krolewski AS, Warram JH, Christleib AR. Hypercholesterolaemia - a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 1994; 45:S125-31.
26. Sawicki P, Didjurgeit U, Mühlhauser I, Bender R, Heinemann L, Berger M. Smoking is associated with the progression of diabetic nephropathy. Diabetes Care 1994; 17:126-31.
27. Alaveras AEG, Thomas SM, Sagriotis A, Viberti G. Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant 1997; 12(suppl 12):71-4.
28. British National Formulary, vol. 36. British Medical Association and The Royal Pharmaceutical Society of Great Britain, 1998.
29. Burton CJ, Feest TG. Does referral to a renal clinic slow the progress of diabetic nephropathy? An audit of 100 consecutive referral. Nephrol Dial Transplant 1998; 13:A108.
30. Bergstöm J, Alvestrand A, Bucht H, Gutierrez A. Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 1986; 25:1-6.
31. Bergström J, Alvestrand A, Bucht H, Gutierrez A. Stockholm clinical study on Progression of chronic renal failure-an interim report. Kidney Int 1989; 38 suppl 27:s110-s114.
32. Gaede P, Vedel P, Parving HH, Pedersen O. Multifactorial intervention delays the progression of long-term complications in patients with Type II diabetes mellitus. Abstracts of the 31st annual meeting of the American Society of Nephrology. Journal of American Society of Nephrology. Baltimore, Williams and Wilkins, 1998:Abstract A0593 p115A.
33. Department of Health. Renal Purchasing Guidelines. London, Department of Health, 1996.